Clinical and economic consequences of failure of initial antibiotic therapy for patients with community-onset complicated intra-abdominal infections

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Chong, Yong Pil ^a   Bae, In Gyu ^b   Lee, Sang Rok ^c   Chung, Jin Won ^d   Jun, Jae Bum ^e   Choo, Eun Ju ^f   Moon, Soo Youn ^g   Lee, Mi Suk ^g   Jeon, Min Hyok ^h   Song, Eun Hee ^a   Lee, Eun Jung ^f   Park, Seong Yeon ⁱ   Kim, Yang Soo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

^c Cheong Ju Saint Mary s Hospital   (South Korea)

^d Chung Ang University College of Medicine   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Soonchunhyang University   (South Korea)

^g Kyung Hee University Hospital   (South Korea)

^h Soonchunhyang University College of Medicine   (South Korea)

ⁱ Dongguk University Ilsan Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEPHALOSPORIN; CEPHAMYCIN; METRONIDAZOLE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BACTEROIDES FRAGILIS; BETA HEMOLYTIC STREPTOCOCCUS; CANDIDA; CITROBACTER; COMMUNITY ONSET COMPLICATED INTRAABDOMINAL INFECTION; CONTROLLED STUDY; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HEALTH CARE COST; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL PATIENT; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PROTEUS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK FACTOR; SERRATIA; SOLID TUMOR; SOUTH KOREA; STAPHYLOCOCCUS AUREUS; TERTIARY CARE CENTER; TREATMENT FAILURE; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; COMMUNITY-ACQUIRED INFECTIONS; HOSPITALIZATION; INTRAABDOMINAL INFECTIONS; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INTRAABDOMINAL INFECTIONS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84929379292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119956     Document Type: Article

References (20)

1. Barie PS, Hydo LJ, Eachempati SR. Longitudinal outcomes of intra-abdominal infection complicated by critical illness. Surgical infections. 2004; 5(4):365-73. PMID: 15744128
2. Christou NV, Barie PS, Dellinger EP, Waymack JP, Stone HH. Surgical Infection Society intra-abdominal infection study. Prospective evaluation of management techniques and outcome. Arch Surg. 1993; 128(2):193-8; discussion 8-9. PMID: 8431120
3. Schein M. Management of severe intra-abdominal infection. Surg Annu. 1992; 24 Pt 1:47-68.
4. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010; 50(2):133-64. doi: 10.1086/649554 PMID: 20034345
5. Cattan P, Yin DD, Sarfati E, Lyu R, De Zelicourt M, Fagnani F. Cost of care for inpatients with community-acquired intra-abdominal infections. Eur J Clin Microbiol Infect Dis. 2002; 21(11):787-93. PMID: 12461588
6. Edelsberg J, Berger A, Schell S, Mallick R, Kuznik A, Oster G. Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surgical infections. 2008; 9(3):335-47. doi: 10.1089/sur.2006.100 PMID: 18570575
7. Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis. 2004; 23(9):682-7. PMID: 15322931
8. Tellado JM, Sen SS, Caloto MT, Kumar RN, Nocea G. Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain. Scand J Infect Dis. 2007; 39(11-12):947-55.
9. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E, Tigecycline 301 Study G, et al. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis. 2005; 41 Suppl 5:S354-67. PMID: 16080073
10. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007; 298(15):1763-71. PMID: 17940231
11. Chen YH, Hsueh PR. Changing bacteriology of abdominal and surgical sepsis. Curr Opin Infect Dis. 2012; 25(5):590-5. doi: 10.1097/QCO.0b013e32835635cb PMID: 22744317
12. Blot S, De Waele JJ. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs. 2005; 65(12):1611-20. PMID: 16060697
13. Montravers P, Chalfine A, Gauzit R, Lepape A, Pierre Marmuse J, Vouillot C, et al. Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections. Ann Surg. 2004; 239 (3):409-16. PMID: 15075660
14. Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, et al. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother. 2009; 63(4):785-94. doi: 10.1093/jac/dkp005 PMID: 19196742
15. Mazuski JE. Antimicrobial treatment for intra-abdominal infections. Expert Opin Pharmacother. 2007; 8 (17):2933-45. PMID: 18001254
16. Dougherty SH. Antimicrobial culture and susceptibility testing has little value for routine management of secondary bacterial peritonitis. Clin Infect Dis. 1997; 25 Suppl 2:S258-61. PMID: 9310698
17. Kokoska ER, Silen ML, Tracy TF Jr, Dillon PA, Kennedy DJ, Cradock TV, et al. The impact of intraoperative culture on treatment and outcome in children with perforated appendicitis. J Pediatr Surg. 1999; 34(5):749-53. PMID: 10359176
18. Blot S, De Waele JJ, Vogelaers D. Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs 2012; 72:e17-32. doi: 10.2165/11599800-000000000-00000 PMID: 22480338
19. Towfigh S, Pasternak J, Poirier A, Leister H, Babinchak T. A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections. Clin Microbiol Infect. 2010; 16(8):1274-81. doi: 10.1111/j.1469-0691.2010.03122.x PMID: 20670293
20. Moore-Gillon JC, Eykyn SJ, Phillips I. Microbiology of pyogenic liver abscess. Br Med J (Clin Res Ed). 1981; 283(6295):819-21. PMID: 6794712